Short‐duration treatment with the novel non‐nucleoside inhibitor CDI‐31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open‐label study.

Published in:

Journal of Medical Virology, 2021, v. 93, n. 6, p. 3752, doi. 10.1002/jmv.26652

By:

• Chua, Joel V.;
• Ntem‐Mensah, Afua;
• Abutaleb, Ameer;
• Husson, Jennifer;
• Mutumbi, Lydiah;
• Lam, Ka Wing;
• Ghosh, Alip;
• Romani, Sara;
• Poonia, Bhawna;
• Lee, Sam;
• Luz Pascual, M.;
• Frumkin, Lyn R.;
• Kottilil, Shyamsundaran

Publication type:

Article